» Articles » PMID: 36004196

Commentary: Evidence-based Human Stem Cell Therapy for Myocardial Healing: Miles to Go

Overview
Journal JTCVS Open
Date 2022 Aug 25
PMID 36004196
Authors
Affiliations
Soon will be listed here.
References
1.
Patel V, Mathison M, Singh V, Yang J, Rosengart T . Direct Cardiac Cellular Reprogramming for Cardiac Regeneration. Curr Treat Options Cardiovasc Med. 2016; 18(9):58. PMC: 5278776. DOI: 10.1007/s11936-016-0480-8. View

2.
Park S, Kim R, Park B, Lee S, Choi S, Park J . Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction. Nat Commun. 2019; 10(1):3123. PMC: 6635499. DOI: 10.1038/s41467-019-11091-2. View

3.
Ikhapoh I, Pelham C, Agrawal D . Synergistic effect of angiotensin II on vascular endothelial growth factor-A-mediated differentiation of bone marrow-derived mesenchymal stem cells into endothelial cells. Stem Cell Res Ther. 2015; 6:4. PMC: 4417220. DOI: 10.1186/scrt538. View

4.
Mazine A, Rushani D, Yau T . Clinical mesenchymal stem cell therapy in ischemic cardiomyopathy. JTCVS Open. 2022; 8:135-141. PMC: 9390513. DOI: 10.1016/j.xjon.2021.06.030. View

5.
Hare J, Chaparro S . Cardiac regeneration and stem cell therapy. Curr Opin Organ Transplant. 2008; 13(5):536-42. PMC: 3966209. DOI: 10.1097/MOT.0b013e32830fdfc4. View